- Isolating Human Antibodies from the Human Repertoire.- What we have learnt from Non-Traditional Antibodies formats so far.This year’s 2-days-programme is organized into 9 tracks covering the hot topics in antibody, cell & gene therapy and other biopharmaceuticals research and development: The Scientific committee has set-up an exciting program, with keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies. The AIS2023 is the ideal conference for scientists, industrials, physicians and policy makers to exchange about therapeutic antibodies and more! It is part of the series of Industrial Symposia organized by MAbImprove since 2013, whose previous topics were: Antibodies Biosimilars, MAbDosing, MAbDelivery, Current & Next Generation Antibody Formats, Antibody Drug Conjugates, Targets for Mabs, Harnessing the Immune System with Abs, and Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases. This international congress is jointly organized by the scientific society LabEx MAbImprove and the industrial organization MabDesign. We are proud to announce the 11th Antibody Industrial Symposium 2023 (AIS2023) that will be held from 22nd to 23rd June 2023 in person in Tours, France. Welcome to the 11th AIS 2023 Antibody Industrial Symposium 2023
0 Comments
Leave a Reply. |